These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7514791)

  • 1. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
    De Dios I; Manso MA
    Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of adrenalectomized rats.
    Manso MA; De Dios I
    Pancreas; 1993 May; 8(3):362-7. PubMed ID: 8483879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of CCK on CDE diet-induced acute pancreatitis in rats treated with hydrocortisone.
    Manso MA; Rebollo A; Pescador R; de Dios I
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jun; 111(2):257-63. PubMed ID: 8521247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M; Sogabe H; Ito H; Matsuo T; Satoh Y; Motoyama Y; Tanaka H
    Pancreas; 1998 Jul; 17(1):57-64. PubMed ID: 9667521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic administration of hydrocortisone on the induction and evolution of acute pancreatitis induced by cerulein.
    Pescador R; Manso MA; Rebollo AJ; de Dios I
    Pancreas; 1995 Aug; 11(2):165-72. PubMed ID: 7479674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
    Wisner JR; Ozawa S; Xue BG; Renner IG
    Pancreas; 1990 Jul; 5(4):434-8. PubMed ID: 1696382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
    Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
    Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T; Tachibana I; Otsuki M
    Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.
    Tachibana I; Otsuki M
    Dig Dis Sci; 1994 Jun; 39(6):1321-8. PubMed ID: 8200267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
    Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of L364718 on interdigestive pancreatic exocrine secretion and gastroduodenal motility in conscious sheep.
    Onaga T; Mineo H; Kato S
    Regul Pept; 1997 Jan; 68(2):139-46. PubMed ID: 9110386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exocrine pancreatic response to CCK in rats after long-term hydrocortisone administration.
    Manso MA; De Dios I; San Roman JI; Martin M; Lopez MA
    Peptides; 1990; 11(2):237-42. PubMed ID: 2356155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
    Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.